Veritable, L.P. Abb Vie Inc. Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $82,686 - $102,897	624 Added 0.55%	115,021 $15.5 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.52 Million - $1.75 Million	-10,531 Reduced 8.43%	114,397 $18.2 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $140,522 - $168,523	1,016 Added 0.82%	124,928 $20.2 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $4.46 Million - $5.12 Million	-33,266 Reduced 21.16%	123,912 $16.6 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $6.04 Million - $7.67 Million	43,856 Added 38.7%	157,178 $24.1 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $405,442 - $503,040	-3,072 Reduced 2.64%	113,322 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $370,633 - $468,958	3,450 Added 3.05%	116,394 $15.8 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $108,528 - $123,195	1,020 Added 0.91%	112,944 $12.2 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $781,499 - $870,635	-7,428 Reduced 6.22%	111,924 $12.6 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $252,169 - $277,608	2,465 Added 2.11%	119,352 $12.9 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $180,217 - $243,312	-2,239 Reduced 1.88%	116,887 $12.5 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $38,487 - $45,171	-448 Reduced 0.37%	119,126 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $731,132 - $978,363	9,965 Added 9.09%	119,574 $11.7 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $7.27 Million - $11 Million	-112,636 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $74,005 - $92,596	-1,026 Reduced 0.9%	112,636 $9.97 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $87,101 - $104,720	-1,383 Reduced 1.2%	113,662 $8.61 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $89,680 - $114,632	1,365 Added 1.2%	115,045 $8.37 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $29,544 - $34,772	-383 Reduced 0.34%	113,680 $9.16 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $60,100 - $74,119	-772 Reduced 0.67%	114,063 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $349,771 - $388,836	3,934 Added 3.55%	114,835 $10.9 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $115,905 - $137,142	-1,291 Reduced 1.15%	110,901 $10.3 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $203,526 - $272,540	-2,212 Reduced 1.93%	112,192 $10.6 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $1.79 Million - $1.96 Million	-19,991 Reduced 14.87%	114,404 $11.1 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $9.39 Million - $12 Million	134,395	134,395 $11.9 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account